IRONWOOD PHARMACEUTICALS, INC. Debt Instrument, Convertible, Carrying Amount of Equity Component
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Debt Instrument, Convertible, Carrying Amount of Equity Component of $112.31 million as of 2021-12-31, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent · last filed 2022-11-03
- 2021-12-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $112.31M.
- 2021-09-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $112.31M.
- 2021-06-30: Debt Instrument, Convertible, Carrying Amount of Equity Component $112.31M.
- 2021-03-31: Debt Instrument, Convertible, Carrying Amount of Equity Component $112.31M.
| Period end | Debt Instrument, Convertible, Carrying Amount of Equity Component |
|---|---|
| 2021-12-31 | $112.31M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $112.31M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $112.31M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $112.31M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $112.31M 10-Q · filed 2021-11-04 |
| 2015-12-31 | $114.20M 10-K · filed 2017-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |